Stock listing

CTNM Stock Price, News, Filings & Events — Contineum Therapeutics, Inc.

Selected listing: CTNM · NASDAQ · USD · US

This page tracks Contineum Therapeutics, Inc.'s CTNM:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CTNM:NASDAQ. CTNM:NASDAQ is the stock-level entry point for investors researching Contineum Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Contineum Therapeutics, Inc. (CTNM) is a public company based in the United States with a market capitalization of approximately $532 million. The company focuses on developing innovative therapeutic solutions. As a publicly traded entity, CTNM is listed on the American stock market, providing investors with opportunities to engage in its growth and development.